Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
出版年份 2021 全文链接
标题
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions
作者
关键词
-
出版物
LANCET
Volume 398, Issue 10306, Pages 1184-1194
出版商
Elsevier BV
发表日期
2021-06-25
DOI
10.1016/s0140-6736(21)00244-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study
- (2021) Ludwig Kappos et al. JAMA Neurology
- Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson’s Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model
- (2020) Élise Pépin et al. Frontiers in Pharmacology
- Fingolimod inhibits multiple stages of the HIV-1 life cycle
- (2020) Rachel S. Resop et al. PLoS Pathogens
- Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
- (2020) Frédéric London et al. Multiple Sclerosis and Related Disorders
- Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
- (2020) Brian G Feagan et al. Lancet Gastroenterology & Hepatology
- P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study
- (2020) Danese Silvio et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- DOP48 Amiselimod, a selective S1P receptor modulator in Crohn’s disease patients: a proof-of-concept study
- (2019) G D’Haens et al. Journal of Crohns & Colitis
- Blockage of sphingosine‐1‐phosphate receptor 2 attenuates allergic asthma in mice
- (2019) Soo‐Jin Park et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
- (2019) Isabel Carreras et al. Scientific Reports
- Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy
- (2019) David M. Ryba et al. Circulation-Heart Failure
- Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial
- (2019) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
- (2019) Giancarlo Comi et al. LANCET NEUROLOGY
- Sphingolipid Metabolism Perturbations in Rett Syndrome
- (2019) Cappuccio et al. Metabolites
- Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
- (2018) Katherine Stockstill et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
- (2018) Richard Hughes et al. LANCET NEUROLOGY
- Progressive multifocal leukoencephalopathy after fingolimod treatment
- (2018) Joseph R. Berger et al. NEUROLOGY
- S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and PressureNovelty and Significance
- (2017) Anna Cantalupo et al. HYPERTENSION
- Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
- (2017) James D. Berry et al. MUSCLE & NERVE
- Genome-wide in vivo screen identifies novel host regulators of metastatic colonization
- (2017) Louise van der Weyden et al. NATURE
- FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits
- (2017) Alexander M. Stessin et al. NEUROSCIENCE LETTERS
- Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1
- (2017) Keisuke Yanagida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- S1P1 deletion differentially affects TH17 and Regulatory T cells
- (2017) Ahmet Eken et al. Scientific Reports
- FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice
- (2016) Ferenc Boldizsar et al. CARDIOVASCULAR PATHOLOGY
- Recent advances in the development of sphingosine kinase inhibitors
- (2016) Melissa R. Pitman et al. CELLULAR SIGNALLING
- Characterization of white matter abnormalities in early-stage schizophrenia
- (2016) Tom A. Hummer et al. Early Intervention in Psychiatry
- Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis
- (2016) Nasr Y. A. Hemdan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy
- (2016) Deron R. Herr et al. Scientific Reports
- Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic StrokeCLINICAL PERSPECTIVE
- (2015) Zilong Zhu et al. CIRCULATION
- SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice
- (2015) Jianning Dong et al. IMMUNOLOGIC RESEARCH
- Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
- (2014) John Camm et al. AMERICAN HEART JOURNAL
- Effects of Topical Sphingosine-1-Phosphate 1 Receptor Agonist on Corneal Allograft in Mice
- (2014) Liang Jia et al. CORNEA
- Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility
- (2014) Lillian Cruz-Orengo et al. JOURNAL OF CLINICAL INVESTIGATION
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) Andrea Vaclavkova et al. LANCET
- Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
- (2014) Nele Claes et al. PLoS One
- Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: Immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy
- (2014) John R. Teijaro et al. VIROLOGY
- Fingolimod for the Treatment of Intracerebral Hemorrhage
- (2014) Ying Fu et al. JAMA Neurology
- FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
- (2013) Alba Di Pardo et al. HUMAN MOLECULAR GENETICS
- Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis
- (2013) Katrin Schaper et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- S1P1localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity
- (2013) David C. Montrose et al. JOURNAL OF LIPID RESEARCH
- Sphingosine-1-Phosphate-Induced Nociceptor Excitation and Ongoing Pain Behavior in Mice and Humans Is Largely Mediated by S1P3 Receptor
- (2013) M. Camprubi-Robles et al. JOURNAL OF NEUROSCIENCE
- Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development
- (2012) Bongnam Jung et al. DEVELOPMENTAL CELL
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
- (2012) Jenny S. Henkel et al. EMBO Molecular Medicine
- Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis
- (2012) Suriyan Ponnusamy et al. EMBO Molecular Medicine
- Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage
- (2012) William B. Rolland et al. EXPERIMENTAL NEUROLOGY
- Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
- (2012) A. Estrada-Bernal et al. NEURO-ONCOLOGY
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
- (2012) R. Deogracias et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice
- (2012) Takumi Tsuji et al. Journal of Diabetes Investigation
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
- (2011) John R. Teijaro et al. CELL
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
- (2011) Bhupendra Khatri et al. LANCET NEUROLOGY
- FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study
- (2011) Andries J. Hoitsma et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice
- (2010) Seiichiro Ando et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice
- (2010) Tongsen Zheng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sphingosine 1-Phosphate Receptor Signaling
- (2009) Hugh Rosen et al. Annual Review of Biochemistry
- T-bet–dependent S1P5expression in NK cells promotes egress from lymph nodes and bone marrow
- (2009) Craig N. Jenne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Treatment with Immunosuppressants FTY720 and Tacrolimus Promotes Functional Recovery after Spinal Cord Injury in Rats
- (2009) Jie Zhang et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started